Dr. Gary R. Morrow, a Pioneer in Cancer Research, Dies at 82
Dr. Gary R. Morrow, a Pioneer in Cancer Research, Dies at 82 The ASCO Post
Онкология
🎗️Лента новостей
Онкология
A microscopic obstacle course hints at how disorder may prime tumor cells for invasion
In 2024, malignant tumors caused more than 21,300 deaths in Austria, 4.7% more than in 2014. Faced with a similarly pressing global challenge, scientists are striving to better understand what drives cancer cells to grow, spread and invade healthy tissue.
Онкология
Как современные исследования меняют лечение рака груди
Как современные исследования меняют лечение рака груди smartpress.by
Онкология
Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea
Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea STAT
🎗️
Онкология
FDA Expands Sevabertinib Indication for Nonsquamous Non-Small Cell Lung Cancer
FDA Expands Sevabertinib Indication for Nonsquamous Non-Small Cell Lung Cancer Oncology News Central
Онкология
New Huntsman cancer campus takes shape in Vineyard
New Huntsman cancer campus takes shape in Vineyard Lehi Free Press
Онкология
Blood-Based OPG Testing May Detect and Track Bone Metastases in Medullary Thyroid Cancer
Blood-Based OPG Testing May Detect and Track Bone Metastases in Medullary Thyroid Cancer Clinical Lab Products
🎗️
Онкология
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients Cure Today
Онкология
Guardant360 CDx Test Approved for Early, ‘Serial’ Use in Breast Cancer
Guardant360 CDx Test Approved for Early, ‘Serial’ Use in Breast Cancer Inside Precision Medicine
Онкология
FDA Approves Camizestrant for ESR-1 Mutated Breast Cancer
FDA Approves Camizestrant for ESR-1 Mutated Breast Cancer Breast Cancer Research Foundation | BCRF
Онкология
Blood test could monitor bone metastasis in medullary thyroid cancer
Researchers at The University of Texas MD Anderson Cancer Center have uncovered a possible reason why metastatic medullary thyroid cancer causes abnormal bone growth, pointing to a new opportunity to detect and monitor bone metastases in patients.
Онкология
Study shows how the microbiome shapes lung cancer immunotherapy outcomes - news-medical.net
Study shows how the microbiome shapes lung cancer immunotherapy outcomes news-medical.net
Онкология
We designed a new way to build miniature fluidic devices to enable personalized cancer treatment
There is no "one-size-fits-all" treatment for patients living with cancer. Cancer occurs when normal cells in the body genetically mutate and transform into abnormal cells that divide uncontrollably.
Онкология
Inhibitor may turn tumor-protecting immune cells against glioblastoma
Mayo Clinic researchers have identified a potential new approach to treating glioblastoma that could help the immune system fight the aggressive brain cancer while improving the effectiveness of existing chemotherapy.